Role of sphingolipids in oestrogen signalling in breast cancer cells: An update

Journal of Endocrinology

Volumn 220, Issue 3, 2014, Pages

  Sukocheva, O ^a   Wadham, C ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Breast cancer; Oestrogen; Sphingosine 1 phosphatereceptor

Indexed keywords

BREAST CANCER; OESTROGEN; SPHINGOSINE-1-PHOSPHATE RECEPTOR;

ANIMALS; BREAST NEOPLASMS; ESTROGENS; FEMALE; HUMANS; SIGNAL TRANSDUCTION; SPHINGOLIPIDS;

EID: 84894315496     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0388     Document Type: Review

References (84)

1. Alvarez SE, Milstien S& Spiegel S 2007 Autocrine and paracrine roles of sphingosine-1-phosphate. Trends in Endocrinology and Metabolism 18 300-307. (doi:10.1016/j.tem.2007.07.005)
2. Antoon JW, White MD, Meacham WD, Slaughter EM, Muir SE, Elliott S, Rhodes LV, Ashe HB, Wiese TE, Smith CD et al. 2010 Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640. Endocrinology 151 5124-5135. (doi:10.1210/en.2010-0420)
3. Antoon JW,MeachamWD, Bratton MR, Slaughter EM, Rhodes LV, Ashe HB, Wiese TE, Burow M,amp; Beckman BS 2011a Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer. Journal of Molecular Endocrinology 46 205-216. (doi:10.1530/JME-10-0116)
4. Antoon JW, White MD, Slaughter EM, Driver JL, Khalili HS, Elliott S, Smith CD, Burow ME& Beckman BS 2011b Targeting NFkB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2. Cancer Biology& Therapy 11 678-689. (doi:10.4161/cbt.11.7.14903)
5. Antoon JW, White MD, Burow ME& Beckman BS 2012 Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance. Oncology Reports 27 1779-1786. (doi:10.3892/or.2012.1743)
6. Aoyagi T, Nagahashi M, Yamada A& Takabe K 2012 The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. Lymphatic Research and Biology 10 97-106. (doi:10.1089/ lrb.2012.0010)
7. Auge N, Garcia V, Maupas-Schwalm F, Levade T, Salvayre R& Negre-Salvayre A 2002 Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arteriosclerosis, Thrombosis, and Vascular Biology 22 1990-1995. (doi:10.1161/01.ATV.0000043453. 21629.3B)
8. Bao M, Chen Z, Xu Y, Zhao Y, Zha R, Huang S, Liu L, Chen T, Li J, Tu H et al. 2012 Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma. Liver International 32 331-338. (doi:10.1111/j.1478-3231.2011.02666.x)
9. Beljanski V, Knaak & Smith CD 2010 A novel sphingosine kinase inhibitor induces autophagy in tumor cells. Journal of Pharmacology and Experimental Therapeutics 333 454-464. (doi:10.1124/jpet.109.163337)
10. Brinkmann V& Lynch KR 2002 FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Current Opinion in Immunology 14 569-575. (doi:10.1016/ S0952-7915(02)00374-6)
11. Chipuk JE,McStay GP, Bharti A, Kuwana T, Clarke CJ, Siskind LJ, Obeid LM& Green DR 2012 Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 148 988-1000. (doi:10.1016/j.cell.2012.01.038)
12. Contreras FX, Ernst AM, Haberkant P, Björkholm P, Lindahl E, Gönen B, Tischer C, Elofsson A, von Heijne G, Thiele C et al. 2012 Molecular recognition of a single sphingolipid species by a protein's transmembrane domain. Nature 481 525-529. (doi:10.1038/nature10742)
13. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind, Spiegel S 1996 Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381 800-803. (doi:10.1038/ 381800a0)
14. Cuvillier O, Rosenthal DS, Smulson ME& Spiegel S 1998 Sphingosine 1-phosphate inhibits activation of caspases that cleave poly (ADP-ribose) polymerase and lamins during Fas- and ceramidemediated apoptosis in Jurkat T lymphocytes. Journal of Biological Chemistry 273 2910-2916. (doi:10.1074/jbc.273.5.2910)
15. Cuvillier O, Nava VE, Murthy SK, Edsall LC, Levade T, Milstien S& Spiegel S 2001 Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells. Cell Death and Differentiation 8 162-171. (doi:10.1038/sj.cdd.4400793)
16. Cyster JG& Schwab SR 2012 Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annual Review of Immunology 30 69-94. (doi:10.1146/annurev-immunol-020711-075011)
17. Döll F, Pfeilschifter J& Huwiler A 2005 The epidermal growth factor stimulates sphingosine kinase-1 expression and activity in the human mammary carcinoma cell lineMCF7. Biochimica et Biophysica Acta 1738 72-81.
18. Doll F, Pfeilschifter J& Huwiler A 2007 Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration. Endocrine-Related Cancer 14 325-335. (doi:10.1677/ERC-06-0050)
19. Driggers PH& Segars JH 2002 Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling. Trends in Endocrinology and Metabolism 13 422-427. (doi:10.1016/S1043-2760(02)00634-3)
20. Du W, Takuwa N, Yoshioka K, Okamoto Y, Gonda K, Sugihara K, Fukamizu A, Asano M& Takuwa Y 2010 S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice. Cancer Research 70 772-781. (doi:10.1158/0008-5472.CAN-09-2722)
21. Duffy MJ 2013 The war on cancer: are we winning? Tumour Biology 34 1275-1284. (doi:10.1007/s13277-013-0759-2)
22. Edsall LC, Cuvillier O, Twitty S, Spiegel S& Milstien S 2001 Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. Journal of Neurochemistry 76 1573-1584. (doi:10.1046/j.1471- 4159.2001.00164.x)
23. El-Shewy HM, Johnson KR, Lee MH, Jaffa AA, Obeid LM& Luttrell LM 2006 Insulin-like growth factors mediate heterotrimeric G proteindependent ERK1/2 activation by transactivating sphingosine-1- phosphate receptors. Journal of Biological Chemistry 281 31399-31407. (doi:10.1074/jbc.M605339200)
24. El-Shewy HM, Abdel-Samie SA, Al Qalam AM, Lee MH, Kitatani K, Anelli V, Jaffa AA, Obeid LM& Luttrell LM 2011 Phospholipase C and protein kinase C-b 2 mediate insulin-like growth factor II-dependent sphingosine kinase 1 activation. Molecular Endocrinology 25 2144-2156. (doi:10.1210/me.2011-0101)
25. English D, Kovala AT& Welch Z 1999 Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis. Journal of Hematotherapy& Stem Cell Research 8 627-634. (doi:10.1089/152581699319795)
26. Filardo EJ& Thomas P 2012 Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology 153 2953-2962. (doi:10.1210/en.2012-1061)
27. French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, Yun JK& Smith CD 2003 Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Research 63 5962-5969.
28. Fukuhara S, Simmons S, Kawamura S, Inoue A, Orba Y, Tokudome T, Sunden Y, Arai Y, Moriwaki K, Ishida J et al. 2012 The sphingosine- 1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. Journal of Clinical Investigation 122 1416-1426. (doi:10.1172/JCI60746)
29. Furuya H, Shimizu Y& Kawamori T 2011 Sphingolipids in cancer. Cancer Metastasis Reviews 30 567-576. (doi:10.1007/s10555-011-9304-1)
30. Gao P, Peterson YK, Smith RA& Smith CD 2012 Characterization of isoenzyme-selective inhibitors of human sphingosine kinase. PLoS ONE 7 e44543. (doi:10.1371/journal.pone.0044543)
31. Goetzl EJ, Dolezalova H, Kong Y& Zeng L 1999a Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells. Cancer Research 59 4732-4737.
32. Goetzl EJ, Kong Y& Mei B 1999b Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. Journal of Immunology 162 2049-2056.
33. Hait NC, Oskeritzian CA, Paugh SW, Milstien S& Spiegel S 2006 Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochimica et Biophysica Acta 1758 2016-2026. (doi:10.1016/j.bbamem. 2006.08.007)
34. Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, Singh SK, Luo C, Marmorstein R, Kordula T, Milstien S et al. 2009 Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325 1254-1257. (doi:10.1126/science.1176709)
35. Hänel P, Andrèani, Gräler MH 2007 Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB Journal 21 1202-1209. (doi:10.1096/fj.06-7433com)
36. Hannun YA& Obeid LM 2008 Principles of bioactive lipid signalling: lessons from sphingolipids. Nature Reviews. Molecular Cell Biology 9 139-150. (doi:10.1038/nrm2329)
37. Hayden MS& Ghosh S 2012 NF-kB, the first quarter-century: remarkable progress and outstanding questions. Genes and Development 26 203-234. (doi:10.1101/gad.183434.111)
38. Hobson JP, Rosenfeldt HM, Barak LS, Olivera A, Poulton S, Caron MG, Milstien S& Spiegel S 2001 Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 291 1800-1803. (doi:10.1126/science.1057559)
39. Holthuis JC, Pomorski T, Raggers RJ, Sprong H& Van Meer G 2001 The organizing potential of sphingolipids in intracellular membrane transport. Physiological Reviews 81 1689-1723.
40. Hsu A, Zhang W, Lee JF, An J, Ekambaram P, Liu J, Honn KV, Klinge CM& Lee MJ 2012 Sphingosine-1-phosphate receptor-3 signaling upregulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells. International Journal of Oncology 40 1619-1626. (doi:10.3892/ijo.2012.1379)
41. Kveberg L, Bryceson Y, Inngjerdingen M, Rolstad B& Maghazachi AA 2003 Sphingosine 1 phosphate induces the chemotaxis of human natural killer cells. Role for heterotrimeric G proteins and phosphoinositide 3 kinases. European Journal of Immunology 32 1856-1864. (doi:10.1002/ 1521-4141(200207)32:7%3C;1856::AID-IMMU1856%3E;3.0.CO;2-B)
42. Lebman DA & Spiegel S 2008 Cross-talk at the crossroads of sphingosine- 1-phosphate, growth factors, and cytokine signaling. Journal of Lipid Research 49 1388-1394. (doi:10.1194/jlr.R800008-JLR200)
43. Leclercq TM, Moretti PAB, Vadas MA& Pitson SM 2008 Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity. Journal of Biological Chemistry 283 9606-9614. (doi:10.1074/jbc.M708782200)
44. Lee OH, Kim YM& Lee YM 1999 Sphingosine-1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochemical and Biophysical Research Communications 264 743-750. (doi:10.1006/bbrc.1999.1586)
45. Limaye V, Li X, Hahn C, Xia P, Berndt MC, Vadas MA& Gamble JR 2005 Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. Blood 105 3169-3177. (doi:10.1182/blood-2004- 02-0452)
46. Liu H, Toman RE, Goparaju SK, Maceyka M, Nava VE, Sankala H, Payne SG, Bektas M, Ishii I, Chun J et al. 2003 Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. Journal of Biological Chemistry 278 40330-40336. (doi:10.1074/jbc.M304455200)
47. Long JS, Edwards J, Watson C, Tovey S, Mair KM, Schiff R, Natarajan V, Pyne N,amp; Pyne S 2010 Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells. Molecular and Cellular Biology 30 3827-3841. (doi:10.1128/MCB.01133-09)
48. Lucki NC& Sewer MB 2011 Genistein stimulates MCF-7 breast cancer cell growth by inducing acid ceramidase (ASAH1) gene expressionJournal of Biological Chemistry 286 19399-19409. (doi:10.1074/jbc. M110.195826)
49. Martin JL, Lin MZ, McGowan EM& Baxter RC 2009 Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity. Journal of Biological Chemistry 284 25542-25552. (doi:10.1074/jbc.M109.007120)
50. Matloubian M, Lo CG& Cinamon G 2004 Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427 355-360. (doi:10.1038/nature02284)
51. Meacham WD, Antoon JW, Burow ME, Struckhoff AP& Beckman B 2009 Sphingolipids as determinants of apoptosis and chemoresistance in the MCF-7 cell model system. Experimental Biology and Medicine 234 1253-1263. (doi:10.3181/0902-MR-77)
52. Meissner A, Yang J, Kroetsch JT, Sauvè M, Dax H, Momen A, Noyan-Ashraf MH, Heximer S, Husain M, Lidington D et al. 2012 TNFa-mediated down-regulation of CFTR drives pathological S1P signaling in a mouse model of heart failure. Circulation 125 2739-2750. (doi:10.1161/CIRCULATIONAHA.111.047316)
53. Montagut C, Tusquets I, Ferrer B, Corominas JM, Bellosillo B, Campas C, Suarez M, Fabregat X, Campo E, Gascon P et al. 2006 Activation of NF-kB is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocrine-Related Cancer 13 607-616. (doi:10.1677/ erc.1.01171)
54. Nagahashi M, Ramachandran S, Kim EY, Allegood JC, Rashid OM, Yamada A, Zhao R, Milstien S, Zhou H, Spiegel S et al. 2012 Sphingosine- 1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Research 72 726-735. (doi:10.1158/0008-5472.CAN-11-2167)
55. Nakade Y, Bano Y, Koizume KT, Hagiwara K, Sobue S, Koda M, Suzuki M, Kojima T, Takagi A, Asano H et al. 2003 Regulation of sphingosine kinase 1 gene expression by protein kinase C in human leukaemia cell line MEG-O1. Biochimica et Biophysica Acta 1635 104-116. (doi:10.1016/j.bbalip.2003.11.001)
56. Nava VE, Hobson JP, Murthy S, Milstien S& Spiegel S 2002 Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Experimental Cell Research 281 115-127. (doi:10.1006/excr.2002.5658)
57. Neubauer HA& Pitson SM 2013 Roles, regulation and inhibitors of sphingosine kinase 2. FEBS Journal 280 5317-5336. (doi:10.1111/ febs.12314)
58. Ohotski J, Long JS, Orange C, Elsberger B, Mallon E, Doughty J, Pyne S, Pyne NJ& Edwards J 2012 Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer. British Journal of Cancer 106 1453-1459. (doi:10.1038/bjc.2012.98)
59. Pitson SM, Moretti PA, Zebol JR, Lynn HE, Xia P, Vadas MA& Wattenberg BW 2003 Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO Journal 22 5491-5500. (doi:10.1093/emboj/cdg540)
60. Pitson SM, Xia P, Leclercq TM, Moretti PA, Zebol JR, Lynn HE, Wattenberg BW& Vadas MA 2005 Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. Journal of Experimental Medicine 201 49-54. (doi:10.1084/jem.20040559)
61. Pyne S, Edwards J, Ohotski J& Pyne NJ 2012 Sphingosine 1-phosphate receptors and sphingosine kinase 1: novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers. Frontiers in Oncology 2 168. (doi:10.3389/fonc.2012.00168)
62. Rolin J& Maghazachi AA 2011 Effects of lysophospholipids on tumor microenvironment. Cancer Microenvironment 4 393-403. (doi:10.1007/ s12307-011-0088-1)
63. Rosen H& Goetzl EJ 2005 Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nature Reviews. Immunology 5 560-570. (doi:10.1038/nri1650)
64. Ruckhäberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, Grösch S, Geisslinger G, Holtrich U, Karn T et al. 2008 Microarrayanalysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Research and Treatment 112 41-52. (doi:10.1007/s10549-007-9836-9)
65. Sanchez T, Thangada S, Wu MT, Kontos CD, Wu D, Wu H& Hla T 2005 PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. PNAS 102 4312-4317. (doi:10.1073/pnas.0409784102)
66. Sarkar S, Maceyka M, Hait NC, Paugh SW, Sankala H, Milstien S& Spiegel S 2005 Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Letters 579 5313-5317. (doi:10.1016/j.febslet.2005.08.055)
67. Shu X, Wu W, Mosteller RD& Broek D 2002 Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Molecular and Cellular Biology 22 7758-7768. (doi:10.1128/MCB.22.22.7758-7768.2002)
68. Sobue S, Hagiwara K, Banno Y, Tamiya-Koizumi K, Suzuki M, Takagi A, Kojima T, Asano H, Nozawa Y& Murate T 2005 Transcription factor specificity protein 1 (Sp1) is the main regulator of nerve growth factor-induced sphingosine kinase 1 gene expression of the rat pheochromocytoma cell line, PC12. Journal of Neurochemistry 95 940-949. (doi:10.1111/j.1471-4159.2005.03399.x)
69. Spiegel S& Milstien S 2007 Functions of the multifaceted family of sphingosine kinases and some close relatives. Journal of Biological Chemistry 282 2125-2129. (doi:10.1074/jbc.R600028200)
70. Spiegel S, Olivera A, Zhang H, Thompson EW, Su Y& Berger A 1994 Sphingosine-1-phosphate, a novel second messenger involved in cell growth regulation and signal transduction, affects growth and invasiveness of human breast cancer cells. Breast Cancer Research and Treatment 31 337-348. (doi:10.1007/BF00666166)
71. Sukocheva OA, Wang L, Albanese N, Pitson SM, Vadas MA& Xia P 2003 Sphingosine kinase transmits estrogen signaling in human breast cancer cells. Molecular Endocrinology 17 2002-2012. (doi:10.1210/me. 2003-0119)
72. Sukocheva O, Wadham C, Holmes A, Albanese N, Verrier E, Feng F, Bernal A, Derian CK, Ullrich A, Vadas MA et al. 2006 Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. Journal of Cell Biology 173 301-310. (doi:10.1083/jcb.200506033)
73. Sukocheva O, Wang L, Verrier E, Vadas MA& Xia P 2009 Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway. Endocrinology 150 4484-4492. (doi:10.1210/en.2009-0391)
74. Sukocheva O, Wadham C & Xia P 2013 Estrogen defines the dynamics and destination of transactivated EGF receptor in breast cancer cells: role of S1P 3 receptor and Cdc42. Experimental Cell Research 319 455-465. (doi:10.1016/j.yexcr.2012.10.014)
75. Takabe K, Kim RH, Allegood JC, Mitra P, Ramachandran S, Nagahashi M, Harikumar KB, Hait NC, Milstien S& Spiegel S 2010 Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. Journal of Biological Chemistry 285 10477-10486. (doi:10.1074/jbc.M109.064162)
76. Takuwa N, Du W, Kaneko E, Okamoto Y, Yoshioka K & Takuwa Y 2011 Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1-Jekyll Hidden behind Hyde. American Journal of Cancer Research 1 460-481.
77. Takuwa Y, Okamoto Y, Yoshioka K & Takuwa N 2012 Sphingosine-1- phosphate signaling in physiology and diseases. BioFactors 38 329-337. (doi:10.1002/biof.1030)
78. Thomas P & Dong J 2006 Binding and activation of the seventransmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. Journal of Steroid Biochemistry and Molecular Biology 102 175-179. (doi:10.1016/j.jsbmb. 2006.09.017)
79. Vadas M, Xia P, McCaughan G & Gamble J 2008 The role of sphingosine kinase 1 in cancer: oncogene or non-oncogene addiction? Biochimica et Biophysica Acta 1781 442-447. (doi:10.1016/j.bbalip.2008.06.007)
80. Watson C, Long JS, Orange C, Tannahill CL, Mallon E, McGlynn LM, Pyne S, Pyne NJ& Edwards J 2010 High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients. American Journal of Pathology 177 2205-2215. (doi:10.2353/ajpath.2010.100220)
81. Xia P, Wang L, Gamble JR & Vadas MA 1999 Activation of sphingosine kinase by tumor necrosis factor-a inhibits apoptosis in human endothelial cells. Journal of Biological Chemistry 274 34499-34505. (doi:10.1074/jbc.274.48.34499)
82. Xia P, Gamble JR, Wang L, Pitson SM, Moretti PA, Wattenberg BW, D'Andrea RJ & Vadas MA 2000 An oncogenic role of sphingosine kinase. Current Biology 10 1527-1530. (doi:10.1016/S0960- 9822(00)00834-4)
83. Young N & Van Brocklyn JR 2007 Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness. Experimental Cell Research 313 1615-1627. (doi:10.1016/j.yexcr.2007.02.009)
84. Zhang N, Qi Y, Wadham C,Wang L, Warren A, DiW&Xia P 2010 FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy. Autophagy 6 1157-1167. (doi:10.4161/ auto.6.8.13614)